ABCL
AbCellera Biologics Inc.
$5.24
-0.57%
$1.5B
No data for this timeframe.
Vol
Market Cap$1.5B
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (87%)
Inst. Holders50 funds
Inst. Value$339.2M
Inst. Activity6 buys / 2 sells
Insider Activity3B / 0S
Insider Net $$371.8K
Reddit Sentiment75° Bullish
SEC Reports5
Recent Activity
Jun 11, 2026
Insider
Montalbano John S. was granted 111,701 shares
Director
Jun 11, 2026
Insider
Quake Stephen was granted 111,701 shares
Director
Jun 11, 2026
Insider
Hayden Michael R was granted 111,701 shares
Director
Jun 5, 2026
SEC
AbCellera appointed Dr. Victor Sandor as an independent director on June 1, 2026. Dr. Sandor is a seasoned medical oncol
8-K — Impact 2/10
May 18, 2026
short_volume
Short Volume: ABCL — 61.0% short (2.5M / 4.1M)
Short: 2,520,707 | Exempt: 0 | TRF Vol: 4,132,033 | Short Ratio: 61.0% | Off-exchange volume (dark p
May 11, 2026
SEC
AbCellera reported Q1 2026 revenue of $8.3M (up 96% YoY from $4.2M) and a net loss of $43.2M ($-0.14/share), narrower th
8-K — Impact 7/10
Apr 21, 2026
SEC
Leerink Partners downgrades ABCL to Market Perform — PT $4 (-57%)
ANALYST-DOWNGRADE — Impact 1/10
Inst.
TD Waterhouse Canada Inc. — DOUBLED
9,564,659 shares ($33.6M)
Price Targets
$10.43
+99.0% upside
Strong Buy
Current $5.24
Low $7.00
Median $11.00
High $13.00
7 analysts
$7.00
$13.00
Analyst Ratings
3Strong Buy
10Buy
2Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 5, 2026 | Cantor Fitzgerald | INITIATE | Overweight |
| Apr 10, 2026 | Jones Trading | INITIATE | Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.17 ▲ +15.0% | $-0.19 — $-0.16 | -42% YoY | 3 |
| Next Q | $-0.18 ▲ +13.8% | $-0.19 — $-0.17 | 7% YoY | 3 |
| Current FY | $-0.65 ▲ +7.6% | $-0.71 — $-0.59 | -33% YoY | 5 |
| Next FY | $-0.72 ▲ +8.1% | $-0.80 — $-0.56 | -10% YoY | 4 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BAKER BROS. ADVISORS LP | $105.7M | — |
| Capital World Investors | $46.6M | — |
| TWO SIGMA INVESTMENTS, LP | $36.9M | ADD |
| TD Waterhouse Canada Inc. | $33.6M | DOUBLED |
| BlackRock, Inc. | $14.1M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 11, 2026 | Montalbano John | A | $0.00 |
| Jun 11, 2026 | Quake Stephen | A | $0.00 |
| Jun 11, 2026 | Hayden Michael | A | $0.00 |
| Jun 3, 2026 | Booth Andrew | M | $47.5K |
| May 14, 2026 | Montalbano John | BUY | $95.4K |
Reddit Sentiment
75°
Bullish
Bearish
Neutral
Bullish
50 institutional holders with $339.2M total value (97,154,292 shares) as of 2026-Q1. Top holders: BAKER, Capital, TWO. Net buying activity: 6 institutions added/increased vs 2 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | 30,275,938 | $105.7M | 31.1% | — |
| 2 | Capital World Investors | 13,361,096 | $46.6M | 13.7% | — |
| 3 | TWO SIGMA INVESTMENTS, LP | 10,562,065 | $36.9M | 10.9% | ADD +25.9% |
| 4 | TD Waterhouse Canada Inc. | 9,564,659 | $33.6M | 9.9% | DOUBLED +42576.5% |
| 5 | BlackRock, Inc. | 4,040,236 | $14.1M | 4.2% | — |
| 6 | DRIEHAUS CAPITAL MANAGEMENT LLC | 4,024,779 | $14.0M | 4.1% | DOUBLED +118.4% |
| 7 | GOLDMAN SACHS GROUP INC | 3,751,212 | $13.1M | 3.9% | — |
| 8 | BANK OF AMERICA CORP /DE/ | 2,999,936 | $10.5M | 3.1% | DOUBLED +977.8% |
| 9 | Alyeska Investment Group, L.P. | 2,592,105 | $9.0M | 2.7% | — |
| 10 | TUDOR INVESTMENT CORP ET AL | 2,273,489 | $7.9M | 2.3% | ADD +26.6% |
| 11 | MORGAN STANLEY | 2,224,829 | $7.8M | 2.3% | TRIM -25.9% |
| 12 | RENAISSANCE TECHNOLOGIES LLC | 1,510,629 | $5.3M | 1.6% | TRIM -36.8% |
| 13 | CITADEL ADVISORS LLC | 1,361,105 | $4.8M | 1.4% | TRIM -65.1% |
| 14 | Point72 Asset Management, L.P. | 1,149,325 | $4.0M | 1.2% | — |
| 15 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 911,100 | $3.2M | 0.9% | — |
| 16 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 750,393 | $2.6M | 0.8% | — |
| 17 | STATE STREET CORP | 730,213 | $2.5M | 0.8% | — |
| 18 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 610,423 | $2.1M | 0.6% | DOUBLED +170.0% |
| 19 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 534,100 | $1.9M | 0.5% | — |
| 20 | CITADEL ADVISORS LLC | 429,500 | $1.5M | 0.4% | TRIM -65.1% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| TD Waterhouse Canada Inc. | DOUBLED | 22,412 | 9,564,659 | +42576.5% | $33.6M | 2026-Q1 |
| TUDOR INVESTMENT CORP ET AL | ADD | 1,796,010 | 2,273,489 | +26.6% | $7.9M | 2026-Q1 |
| MORGAN STANLEY | TRIM | 3,001,850 | 2,224,829 | -25.9% | $7.8M | 2026-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 2,389,229 | 1,510,629 | -36.8% | $5.3M | 2026-Q1 |
| GROUP ONE TRADING LLC | ADD | 128,999 | 239,133 | +85.4% | $834.6K | 2026-Q1 |
| ExodusPoint Capital Management, LP | ADD | 113,068 | 142,746 | +26.2% | $498.2K | 2026-Q1 |
| Allworth Financial LP | ADD | 11,274 | 15,401 | +36.6% | $53.8K | 2026-Q1 |
| HRT FINANCIAL LP | DOUBLED | 548,431 | 1,235,153 | +125.2% | $4.3K | 2026-Q1 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | DOUBLED | 1,726,941 | 3,771,999 | +118.4% | $12.9M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 3,360,729 | 2,389,229 | -28.9% | $8.2M | 2025-Q4 |
| TUDOR INVESTMENT CORP ET AL | DOUBLED | 730,122 | 1,796,010 | +146.0% | $6.1M | 2025-Q4 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | DOUBLED | 257,735 | 695,796 | +170.0% | $2.4M | 2025-Q4 |
| LAZARD ASSET MANAGEMENT LLC | TRIM | 652,096 | 328,717 | -49.6% | $1.1M | 2025-Q4 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | TRIM | 736,945 | 209,925 | -71.5% | $717.9K | 2025-Q4 |
| BANK OF MONTREAL /CAN/ | DOUBLED | 65,508 | 146,359 | +123.4% | $500.5K | 2025-Q4 |
| HSBC HOLDINGS PLC | DOUBLED | 24,617 | 117,031 | +375.4% | $400.8K | 2025-Q4 |
| POLEN CAPITAL MANAGEMENT LLC | TRIM | 269,248 | 102,508 | -61.9% | $350.6K | 2025-Q4 |
| Invesco Ltd. | ADD | 42,689 | 54,603 | +27.9% | $186.7K | 2025-Q4 |
| HB Wealth Management, LLC | TRIM | 28,981 | 18,981 | -34.5% | $64.9K | 2025-Q4 |
| Mirae Asset Global Investments Co., Ltd. | ADD | 11,553 | 14,546 | +25.9% | $49.7K | 2025-Q4 |
| Allworth Financial LP | DOUBLED | 1,178 | 11,274 | +857.0% | $38.6K | 2025-Q4 |
| &PARTNERS | TRIM | 15,000 | 10,000 | -33.3% | $34.2K | 2025-Q4 |
| HRT FINANCIAL LP | ADD | 436,575 | 548,431 | +25.6% | $1.9K | 2025-Q4 |
| BAILLIE GIFFORD & CO | EXIT | 10,422,966 | 0 | -100.0% | $0.00 | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | ADD | 4,110,852 | 5,175,142 | +25.9% | $26.0M | 2025-Q3 |
5 unique insiders with 7 transactions. Net insider value: $371.8K ($371.8K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Montalbano John S. | Director | AWARD | 111,701 | — | — |
| Jun 11, 2026 | Quake Stephen | Director | AWARD | 111,701 | — | — |
| Jun 11, 2026 | Hayden Michael R | Director | AWARD | 111,701 | — | — |
| Jun 3, 2026 | Booth Andrew | Chief Financial Officer | EXERCISE | 250,000 | $0.1900 | $47.5K |
| May 14, 2026 | Montalbano John S. | Director | BUY | 20,000 | $4.77 | $95.4K |
| Feb 27, 2026 | Thermopylae Holdings Ltd. | 10%+ Owner | BUY | 38,000 | $3.44 | $130.7K |
| Feb 27, 2026 | Booth Andrew | Chief Financial Officer | BUY | 42,600 | $3.42 | $145.7K |
5 SEC filing reports analyzed. Sentiment: 3 bullish, 1 bearish, 0 mixed, 1 neutral. Avg impact: 4.6/10.
BEARISH
ANALYST-DOWNGRADE
1/10
Leerink Partners downgrades ABCL to Market Perform — PT $4 (-57%)
Apr 21, 2026
NEUTRAL
8-K
2/10
AbCellera appointed Dr. Victor Sandor as an independent director on June 1, 2026. Dr. Sandor is a se
Jun 5, 2026
BULLISH
8-K
7/10
AbCellera reported Q1 2026 revenue of $8.3M (up 96% YoY from $4.2M) and a net loss of $43.2M ($-0.14
May 11, 2026
BULLISH
CLUSTER
6/10
Two insiders at AbCellera Biologics purchased shares in the open market within the same week, includ
Mar 2, 2026
BULLISH
8-K
7/10
AbCellera reported strong financial results for 2025, with revenue nearly tripling to $75.1 million
Feb 24, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (87% buy). Based on 15 analysts: 3 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$10.43 mean target
+99.0% upside
Strong Buy (1.33)
$7.00 Low
$13.00 High
| Metric | Value |
|---|---|
| Current Price | $5.24 |
| Target Low | $7.00 |
| Target Mean | $10.43 |
| Target Median | $11.00 |
| Target High | $13.00 |
| # Analysts | 7 |
| Recommendation | Strong Buy (1.33) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.17 | $-0.19 | $-0.16 | -41.7% | +15.0% | 2↑ 0↓ | $0.0B | -54.1% | 3 |
| Next Q 2026-09-30 |
$-0.18 | $-0.19 | $-0.17 | 7.0% | +13.8% | 2↑ 0↓ | $0.0B | -14.2% | 3 |
| Current FY 2026-12-31 |
$-0.65 | $-0.71 | $-0.59 | -33.5% | +7.6% | 4↑ 0↓ | $0.0B | -57.4% | 5 |
| Next FY 2027-12-31 |
$-0.72 | $-0.80 | $-0.56 | -10.1% | +8.1% | 2↑ 0↓ | $0.0B | -3.4% | 4 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.170 | |
| 7d ago | $-0.198 | +0.027 |
| 30d ago | $-0.200 | +0.030 |
| 60d ago | $-0.200 | +0.030 |
| 90d ago | $-0.175 | +0.005 |
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 2 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 5, 2026 | Cantor Fitzgerald | INITIATE | — | Overweight |
| Apr 10, 2026 | Jones Trading | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 10 | 2 | 0 | 0 | 87% | |
| May 1, 2026 | 3 | 9 | 2 | 0 | 0 | 86% | |
| Apr 1, 2026 | 3 | 9 | 2 | 0 | 0 | 86% | |
| Mar 1, 2026 | 3 | 9 | 2 | 0 | 0 | 86% | |
| Feb 1, 2026 | 3 | 9 | 2 | 0 | 0 | 86% | |
| Jan 1, 2026 | 3 | 9 | 2 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
75°
Bullish
Bearish
Neutral
Bullish
8 mentions
6 bullish
0 bearish
8 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Jun 1, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Jun 1, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 21, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 21, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 10, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 10, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 5, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 5, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
ABCL is the most slept-on biotech binary event of 2026 and you're all too busy buying 0DTE SPY puts to notice
▲ 1
💬 0
⚡ 0.5
Why is ABCL up so much today?
▲ 1
💬 1
⚡ 0.5
AbCellera and the novel hantavirus
▲ 1
💬 0
⚡ 0.5
May 18, 2026
short_volume
Short Volume: ABCL — 61.0% short (2.5M / 4.1M)
Short: 2,520,707 | Exempt: 0 | TRF Vol: 4,132,033 | Short Ratio: 61.0% | Off-exchange volume (dark pool + OTC)
May 12, 2026
short_interest
FTD: ABCL — 108,660 shares ($0.6M) failed to deliver
Settlement: 20260512, Price: $5.25, FTD Value: $570,465, ABCELLERA BIOLOGICS INC. (CAN)
May 11, 2026
earnings_calendar
ABCL Q1 2026 Earnings Scheduled — 2026-05-11
May 11, 2026
short_volume
Short Volume: ABCL — 55.7% short (3.1M / 5.5M)
Short: 3,074,131 | Exempt: 14,048 | TRF Vol: 5,522,973 | Short Ratio: 55.7% | Off-exchange volume (dark pool + OTC)
May 10, 2026
earnings_calendar
ABCL Q1 2026 Earnings Scheduled — 2026-05-10
May 8, 2026
short_volume
Short Volume: ABCL — 62.0% short (4.0M / 6.4M)
Short: 3,961,059 | Exempt: 20,258 | TRF Vol: 6,390,172 | Short Ratio: 62.0% | Off-exchange volume (dark pool + OTC)
May 7, 2026
short_volume
Short Volume: ABCL — 65.0% short (4.7M / 7.2M)
Short: 4,688,216 | Exempt: 8,784 | TRF Vol: 7,217,488 | Short Ratio: 65.0% | Off-exchange volume (dark pool + OTC)
May 6, 2026
short_volume
Short Volume: ABCL — 61.8% short (2.2M / 3.6M)
Short: 2,232,570 | Exempt: 205 | TRF Vol: 3,609,852 | Short Ratio: 61.8% | Off-exchange volume (dark pool + OTC)
May 6, 2026
short_interest
FTD: ABCL — 376,377 shares ($1.8M) failed to deliver
Settlement: 20260506, Price: $4.66, FTD Value: $1,753,916.82, ABCELLERA BIOLOGICS INC. (CAN)
May 5, 2026
short_volume
Short Volume: ABCL — 64.6% short (3.4M / 5.2M)
Short: 3,391,606 | Exempt: 21,102 | TRF Vol: 5,246,430 | Short Ratio: 64.6% | Off-exchange volume (dark pool + OTC)
May 4, 2026
short_volume
Short Volume: ABCL — 66.2% short (2.7M / 4.0M)
Short: 2,655,174 | Exempt: 3,419 | TRF Vol: 4,009,640 | Short Ratio: 66.2% | Off-exchange volume (dark pool + OTC)
Apr 30, 2026
short_interest
FTD: ABCL — 286,808 shares ($1.1M) failed to deliver
Settlement: 20260430, Price: $3.82, FTD Value: $1,095,606.56, ABCELLERA BIOLOGICS INC. (CAN)
Apr 29, 2026
short_interest
FTD: ABCL — 1,786,958 shares ($7.4M) failed to deliver
Settlement: 20260429, Price: $4.16, FTD Value: $7,433,745.28, ABCELLERA BIOLOGICS INC. (CAN)
Apr 28, 2026
short_interest
FTD: ABCL — 619,362 shares ($2.6M) failed to deliver
Settlement: 20260428, Price: $4.16, FTD Value: $2,576,545.92, ABCELLERA BIOLOGICS INC. (CAN)
Apr 27, 2026
short_volume
Short Volume: ABCL — 62.3% short (4.2M / 6.7M)
Short: 4,198,184 | Exempt: 25,612 | TRF Vol: 6,742,063 | Short Ratio: 62.3% | Off-exchange volume (dark pool + OTC)